menu
    • menu

    Company profile for Supriya Lifescience

    Supriya Lifesciences-PSE
    News
    Supriya Lifesciences Saloni & Shivani Wagh in Candere Hurun India

    07 Jun 2025

    // EXPRESSPHARMA

    Supriya Lifescience expands solar power capacity with 5 MWp facility

    19 Mar 2025

    // EXPRESSPHARMA

    Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr

    28 Jan 2025

    // INDPHARMAPOST

    DATA COMPILATION
    #PharmaFlow

    Supriya Lifescience

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Booth #12.0F99

    Book a meeting

    envelop Contact Supplier

    Latest Content

    https://www.youtube.com/embed/GcFi34PmHwc?si=yzKLaw9YooO6_7Hw

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Related CompaniesRelated Companies

    About

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Supriya Lifescienceindia-flag Flag
    Country
    Country
    India
    Address
    Address
    207/208 Udyog Bhavan, Sonawala Road, Goregoan [E], Mumbai – 400 063
    Telephone
    Telephone
    +91 2226860012
    Client Email
    Email
    supriya@supriyalifescience.com
    Client Website
    Website
    https://supriyalifescience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/supriya-lifescience-limited/
    youtube
    YouTube
    https://www.youtube.com/@SupriyaLifescience/videos
    Twitter
    Twitter
    https://x.com/SupriyaLife/
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-45074.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-32145.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    FDF Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-57092.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    API Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-84447.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/supriya-lifescience-party-content-63376.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Every year, the US Food and Drug Administration (FDA) publishes the user fee amounts it will collect from manufacturers of pharmaceuticals, generic drugs, biosimilars and medical devices in the coming financial year. The fee for fiscal year 2025 under the Generic Drug User Fee Act (GDUFA) was published on July 31, 2024.The GDUFA, established in 2012, authorizes FDA to assess and collect fees from drug manufacturers to expedite the delivery of safe, high-quality, and affordable generic drugs to the American public.The FDA’s facility payments list under GDUFA reveals that as of November 14, 2024, 1,397 facilities had paid their registration fees for financial year 2025. Of these facilities, 707 or 50.6 percent are active pharmaceutical ingredients (API) facilities, 405 or 29 percent are finished dosage forms (FDF) facilities, 69 (4.9 percent) are facilities that produce both APIs and FDFs, and 216 (15.5 percent) are contract manufacturing services (CMO) sites.Teva Pharmaceuticals, with 29 facility registrations, led the list of companies, followed by Aurobindo Pharma, Sun Pharma, and Dr. Reddy's Laboratories. Fiscal year Facility Registrations 2016 1,425 2017 1,442 2018 1,269 2019 1,286 2020 1,300 2021 1,340 2022 1,385 2023 1,394 2024 1,447 2025 1,397  Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available)India continues to lead with 396 facilities, US and China follow India maintains its dominance in total facility registrations with the FDA, registering 396 facilities for FY2025. This includes 214 API facilities, 135 FDF facilities, 21 facilities engaged in both API and FDF activities, and 26 CMO facilities.The United States holds the second position with 328 facilities, while China strengthened its third position with 197 facilities.With 214 API facilities, India continues to have the largest share of API manufacturing sites, outmatching the combined total of China (128) and the US (83), which together account for 211 facilities. Among European manufacturers, Italy leads with 59 API manufacturing sites, followed by Spain (30) and Germany (25).The US has maintained its lead in FDF facilities with 143 sites, followed closely by India with 135 sites and China with 45 sites. Country API FDF Both CMO Total India 214 135 21 26 396 US 83 143 13 89 328 China 128 45 12 12 197 Italy 59 3 2 19 83 Germany 25 4 1 15 45 Spain 30 9 1 4 44 Canada 7 17   13 37 Taiwan 9 6 5 4 24 Switzerland 15 4   4 23 France 16     6 22 Japan 18   1   19 United Kingdom 12 1   2 15 Mexico 9 1   1 11 Ireland 5 5   1 11   Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) GDUFA III user fee rates increase across categories for FY25The GDUFA, which was reauthorized on September 30, 2022 (as GDUFA III), continues with provisions that will last until September 30, 2027. In July 2024, the FDA published updated user fee rates for FY2025.The facility fees have seen increases across all categories. API facility fees increased by 3 percent for domestic sites (to US$ 41,580) and 2 percent for foreign sites (to US$ 56,580). FDF facility fees rose by 5 percent for both domestic (to US$ 231,952) and foreign sites (to US$ 246,952). CMO facility fees increased by 5 percent for domestic sites (to US$ 55,668) and 4 percent for foreign sites (to US$ 70,668).Additionally, the fee for large-, medium- and small-sized drug applicants has increased by over 9 percent, compared to the 7 percent increase seen in 2023. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) China leads new facility registrations as FDA records 41 new units in FY25Out of the total 1,397 facilities registered for FY2025, 41 were new registrations (going by Facility FDA Establishment Identifier numbers). China led the way with 13 new facilities, followed closely by India with 11 new facilities, while the US secured the third position with eight new facilities.The new registrations included 15 API facilities, 13 CMO facilities, 12 FDF facilities, and one facility engaged in both API and FDF activities. Chinese companies dominated the new FDF registrations with six facilities: Chengdu Shuode Pharma, Chengdu Suncadia Medicine, Cipla (Jiangsu), GE Healthcare (Shanghai), Luoxin Aurovitas Pharma (Chengdu), and Zhejiang Xianju Pharma.India added two new FDF facilities through Eugia Steriles and Zydus Pharma. Malaysia registered two FDF facilities through Novugen Pharma and Novugen Oncology, while Turkey’s Insud Pharma subsidiary Exeltis and US’ RK Pharma registered one FDF facility each.The 13 new CMO facilities included, Acme Generics, Emcure, Esjay Pharma, Fordoz Pharma, Fourrts Laboratories, Laboratoires KABS, PharmaMax, Quality Packaging Specialists International, Ritsa Pharma, Shanghai Aucyun Pharma, Sichuan Huiyu Pharma, Taejoon Pharm, and Tubilux Pharma.In the API category, the 15 new registrations included Acharya Chemicals, Hainan Poly Pharma, CBL Patras, EUROAPI, Hybio Pharma, Medilux Laboratories, Metrochem API, Purolite, Chengdu Easton Biopharma, Sionc Pharma, Smithfield Bioscience, Xttrium Laboratories, Zhejiang Hengkang Pharma, Moehs Iberica and Shilpa Pharma. Armstrong Pharmaceuticals registered the sole facility for both APIs and FDFs.So far, 92 facilities have not renewed their registration. Among these was a facility owned by Sandoz subsidiary Eon Labs in Wilson, North Carolina (US), which is permanently closed. In fact, the geographical distribution of non-renewals shows that 30 facilities were from the US, while India and China accounted for 14 and nine non-renewals respectively. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) Our viewThe FY 2025 GDUFA facility registration data indicates a continued strong presence of Indian manufacturers in the US generic drug market, particularly in API production. However, China's leadership in new facility registrations, especially in FDF manufacturing, suggests that the global generic drug supply chain landscape may evolve considerably in the coming years. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 13705

    https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities

    #PharmaFlow by PHARMACOMPASS
    21 Nov 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Supriya Lifesciences Saloni & Shivani Wagh in Candere Hurun India
    Supriya Lifesciences Saloni & Shivani Wagh in Candere Hurun India

    07 Jun 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/supriya-lifesciences-saloni-wagh-and-shivani-wagh-named-in-2025-candere-hurun-india-women-leaders-list/

    EXPRESSPHARMA
    07 Jun 2025
    Share Share
    Supriya Lifescience expands solar power capacity with 5 MWp facility
    Supriya Lifescience expands solar power capacity with 5 MWp facility

    19 Mar 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/supriya-lifescience-expands-solar-power-capacity-with-5-mwp-facility-in-maharashtra/

    EXPRESSPHARMA
    19 Mar 2025
    Share Share
    Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr
    Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr

    28 Jan 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/supriya-lifescience-posts-q3-fy25-pat-up-at-rs-4678-cr-16713

    INDPHARMAPOST
    28 Jan 2025
    Share Share
    Union Budget 2025-26: roadmap for India’s pharmaceutical leadership
    Union Budget 2025-26: roadmap for India’s pharmaceutical leadership

    26 Jan 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/union-budget-2025-26-a-roadmap-for-indias-pharmaceutical-leadership/

    EXPRESSPHARMA
    26 Jan 2025
    Share Share
    Supriya opens new API block at Lote Parshuram site in Maharashtra
    Supriya opens new API block at Lote Parshuram site in Maharashtra

    18 Dec 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/supriya-lifescience-opens-new-api-block-at-lote-parshuram-site-in-maharashtra/articleshow/116408363.cms?from=mdr

    ECONOMICTIMES
    18 Dec 2024
    Share Share
    Supriya Lifescience expands global footprint with Esketamine HCL
    Supriya Lifescience expands global footprint with Esketamine HCL

    11 Dec 2024

    // PRESS RELEASE

    https://www.biospectrumindia.com/news/73/25432/supriya-lifescience-expands-global-footprint-with-esketamine-hydrochloride-approval-atorvastatin-patent-filing.html

    PRESS RELEASE
    11 Dec 2024
    Share Share

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Allopurinol

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    01

    Allopurinol

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Allopurinol Sodium

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    02

    Allopurinol Sodium

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Artemether

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    03

    Artemether

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Atorvastatin Calcium

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    04

    Atorvastatin Calcium

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Bisoprolol Fumarate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    05

    Bisoprolol Fumarate

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Brompheniramine Maleate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    06

    Brompheniramine Maleate

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Cetirizine Dihydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    07

    Cetirizine Dihydrochloride

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Chlorpheniramine Maleate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    08

    Chlorpheniramine Maleate

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Closantel

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    09

    Closantel

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Daridorexant

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D...
    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.
    Supriya

    10

    Daridorexant

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience

    Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows industry standards and constantly improves to deliver quality products. Its facility is 47,000 square meters with dedicated areas for warehouse, QA, QC, R&D, production and finished products. The current capacity is 550 KL, with plans to expand to over 1000 KL by 2024. Supriya has 14 active USDMFs, 8 active CEPs, strong R&D and compliant facilities worldwide. Supriya works with innovators, generic companies, and as a CMO.

    About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Supriya follows ...

    Supriya

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience Expands Global Footprint with Esketamine Hydrochloride Approval

    Details:

    Esketamine HCl is a non-selective, non-competitive NMDA receptor antagonist, approved for treating mental illness.


    Lead Product(s): Esketamine Hydrochloride

    Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Controlled Substance

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 09, 2024

    Supriya

    01

    Supriya Lifescience

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Lead Product(s) : Esketamine Hydrochloride

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Supriya Lifescience Expands Global Footprint with Esketamine Hydrochloride Approval

    Details : Esketamine HCl is a non-selective, non-competitive NMDA receptor antagonist, approved for treating mental illness.

    Product Name : Undisclosed

    Product Type : Controlled Substance

    Upfront Cash : Inapplicable

    December 09, 2024

    Supriya

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Supriya Lifescience Signs Agreement with KIT for Further Development of Wound Healing Gel

    Details:

    Through the agreement, Supriya Lifescience will focus on the advancement of GelHeal, a protein-based crosslinked Hydrogel, gel-based cream, which is being evaluated for the treatment of deep wounds.


    Lead Product(s): Crosslinked Hydrogel

    Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: GelHeal

    Study Phase: PreclinicalProduct Type: Other Large Molecule

    Sponsor: Kalinga Institute of Technology

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement June 11, 2023

    Supriya

    02

    Supriya Lifescience

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Lead Product(s) : Crosslinked Hydrogel

    Therapeutic Area : Trauma (Emergency, Injury, Surgery)

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Kalinga Institute of Technology

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Supriya Lifescience Signs Agreement with KIT for Further Development of Wound Healing Gel

    Details : Through the agreement, Supriya Lifescience will focus on the advancement of GelHeal, a protein-based crosslinked Hydrogel, gel-based cream, which is being evaluated for the treatment of deep wounds.

    Product Name : GelHeal

    Product Type : Other Large Molecule

    Upfront Cash : Undisclosed

    June 11, 2023

    Supriya

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India

    Details:

    Revive Therapeutics and Indian specialty pharma firm, Supriya Lifescience have signed an MOU to pursue the manufacturing of the API, conduct clinical registration, and commercialize Bucillamine in the treatment of mild-to-moderate COVID-19 in India.


    Lead Product(s): Bucillamine

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Other Small Molecule

    Sponsor: Revive Therapeutics

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration August 06, 2021

    Supriya

    03

    Supriya Lifescience

    India
    arrow
    CPhI WW Frankfurt
    Booth #12.0F99
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Lead Product(s) : Bucillamine

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Revive Therapeutics

    Deal Size : Undisclosed

    Deal Type : Collaboration

    DEALS_DEV arrow-down

    Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India

    Details : Revive Therapeutics and Indian specialty pharma firm, Supriya Lifescience have signed an MOU to pursue the manufacturing of the API, conduct clinical registration, and commercialize Bucillamine in the treatment of mild-to-moderate COVID-19 in India.

    Product Name : Undisclosed

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    August 06, 2021

    Supriya

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Supriya Lifescience and get a quotation

    Supriya Lifescience is a supplier offers 67 products (APIs, Excipients or Intermediates).

    Find a price of Brompheniramine Maleate bulk with DMF, CEP, WC offered by Supriya Lifescience

    Find a price of Esketamine Hydrochloride bulk with DMF, CEP, WC offered by Supriya Lifescience

    Find a price of Ketamine Hydrochloride bulk with DMF, CEP, WC offered by Supriya Lifescience

    Find a price of Pheniramine Maleate bulk with DMF, CEP, WC offered by Supriya Lifescience

    Find a price of Pyrilamine Maleate bulk with DMF, CEP, WC offered by Supriya Lifescience

    Find a price of Riboflavin 5 Phosphate Sodium bulk with DMF, JDMF, WC offered by Supriya Lifescience

    Find a price of Salbutamol Sulphate bulk with DMF, CEP, WC offered by Supriya Lifescience

    Find a price of Tramadol Hydrochloride bulk with DMF, CEP, WC offered by Supriya Lifescience

    Find a price of Bisoprolol Fumarate bulk with DMF, WC offered by Supriya Lifescience

    Find a price of Cetirizine Dihydrochloride bulk with DMF, WC offered by Supriya Lifescience

    Find a price of Chlorpheniramine Maleate bulk with DMF, WC offered by Supriya Lifescience

    Find a price of Dexchloropheniramine Maleate bulk with DMF, WC offered by Supriya Lifescience

    Find a price of Dextromethorphan Hydrobromide bulk with DMF, WC offered by Supriya Lifescience

    Find a price of Diphenhydramine Hydrochloride bulk with DMF, CEP offered by Supriya Lifescience

    Find a price of Hydroxocobalamin bulk with DMF, WC offered by Supriya Lifescience

    Find a price of Methylcobalamin bulk with DMF, WC offered by Supriya Lifescience

    Find a price of Pentoxifylline bulk with CEP, WC offered by Supriya Lifescience

    Find a price of Allopurinol bulk with DMF offered by Supriya Lifescience

    Find a price of Brompheniramine Maleate bulk with WC offered by Supriya Lifescience

    Find a price of Bupropion Hydrochloride bulk with DMF offered by Supriya Lifescience

    Find a price of Chlorpheniramine bulk with CEP offered by Supriya Lifescience

    Find a price of Dexbrompheniramine Maleate bulk with WC offered by Supriya Lifescience

    Find a price of Hydroxocobalamin bulk with WC offered by Supriya Lifescience

    Find a price of Hydroxocobalamin Acetate bulk with WC offered by Supriya Lifescience

    Find a price of Nicorandil bulk with WC offered by Supriya Lifescience

    Find a price of Pyrilamine Maleate bulk with WC offered by Supriya Lifescience

    Find a price of Riboflavin 5 Phosphate Sodium bulk with WC offered by Supriya Lifescience

    Find a price of Salbutamol Sulphate bulk with WC offered by Supriya Lifescience

    Find a price of Allopurinol Sodium bulk offered by Supriya Lifescience

    Find a price of Artemether bulk offered by Supriya Lifescience

    Find a price of Aspirin bulk offered by Supriya Lifescience

    Find a price of Atorvastatin bulk offered by Supriya Lifescience

    Find a price of Cetirizine Dihydrochloride bulk offered by Supriya Lifescience

    Find a price of Chlorpheniramine Maleate bulk offered by Supriya Lifescience

    Find a price of Closantel Sodium bulk offered by Supriya Lifescience

    Find a price of Colchicine bulk offered by Supriya Lifescience

    Find a price of Daridorexant bulk offered by Supriya Lifescience

    Find a price of Desflurane bulk offered by Supriya Lifescience

    Find a price of Dexchloropheniramine Maleate bulk offered by Supriya Lifescience

    Find a price of Dexmedetomidine Hydrochloride bulk offered by Supriya Lifescience

    Find a price of Dextromethorphan bulk offered by Supriya Lifescience

    Find a price of Enzalutamide bulk offered by Supriya Lifescience

    Find a price of Esketamine Hydrochloride bulk offered by Supriya Lifescience

    Find a price of Gadobutrol bulk offered by Supriya Lifescience

    Find a price of Gadopiclenol bulk offered by Supriya Lifescience

    Find a price of Hydroxocobalamin Hydrochloride bulk offered by Supriya Lifescience

    Find a price of Ibrutinib bulk offered by Supriya Lifescience

    Find a price of Ibuprofen Piconol bulk offered by Supriya Lifescience

    Find a price of Iohexol bulk offered by Supriya Lifescience

    Find a price of Isoflurane bulk offered by Supriya Lifescience

    Find a price of Lidocaine bulk offered by Supriya Lifescience

    Find a price of Lidocaine Hydrochloride bulk offered by Supriya Lifescience

    Find a price of Liraglutide bulk offered by Supriya Lifescience

    Find a price of Lisdexamfetamine Dimesylate bulk offered by Supriya Lifescience

    Find a price of Methylcobalamin bulk offered by Supriya Lifescience

    Find a price of Midazolam bulk offered by Supriya Lifescience

    Find a price of Midazolam Hydrochloride bulk offered by Supriya Lifescience

    Find a price of Midazolam Maleate bulk offered by Supriya Lifescience

    Find a price of Pentobarbital Sodium bulk offered by Supriya Lifescience

    Find a price of Ruxolitinib Phosphate bulk offered by Supriya Lifescience

    Find a price of Semaglutide bulk offered by Supriya Lifescience

    Find a price of Sevoflurane bulk offered by Supriya Lifescience

    Find a price of Sildenafil Citrate bulk offered by Supriya Lifescience

    Find a price of Theobromine bulk offered by Supriya Lifescience

    Find a price of Tigecycline bulk offered by Supriya Lifescience

    Find a price of Tofacitinib Citrate bulk offered by Supriya Lifescience

    Find a price of Tramadol Hydrochloride bulk offered by Supriya Lifescience

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search